HealthEquity shareholders approve all 2026 proposals
HealthEquity, Inc. reported the results of its 2026 Annual Meeting of Stockholders held on June 25, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
HealthEquity, Inc. reported the results of its 2026 Annual Meeting of Stockholders held on June 25, 2026. As of the May 6, 2026 record date, 83,830,457 shares of common stock were outstanding and entitled to vote.
Stockholders elected ten directors to serve until the 2027 annual meeting, with each nominee receiving over 74 million votes in favor. They also ratified PricewaterhouseCoopers LLP as independent auditor for the fiscal year ending January 31, 2027, approved on a non-binding basis the fiscal 2026 executive compensation, and authorized a new 2026 Employee Stock Purchase Plan. In addition, stockholders approved the Amended and Restated 2024 Equity Incentive Plan, supporting the company’s long-term equity-based compensation programs.
8-K Event Classification
Key Figures
Key Terms
broker non-votes financial
non-binding, advisory basis financial
Employee Stock Purchase Plan financial
Equity Incentive Plan financial
independent registered public accounting firm financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did HealthEquity (HQY) stockholders vote on at the 2026 Annual Meeting?
Were all director nominees elected at HealthEquity’s 2026 Annual Meeting?
Did HealthEquity (HQY) stockholders approve the 2026 Employee Stock Purchase Plan?
What were the vote results on HealthEquity’s amended 2024 Equity Incentive Plan?
Who is HealthEquity’s auditor for the fiscal year ending January 31, 2027?
AI-generated analysis. How Rhea-AI works. Not financial advice.